A foundational pillar of cancer research has received significant reinforcement through a new study that confirms the validity of a key laboratory model for high-grade serous ovarian carcinoma (HGSOC), the most lethal form of ovarian cancer. This disease presents a formidable clinical challenge,
With a staggering rise in mouth cancer rates across India, new research is revealing the insidious role of even moderate alcohol consumption. To unpack these alarming findings, we spoke with Ivan Kairatov, a biopharma expert whose work at the intersection of technology and public health provides a
Deep within the microscopic confines of every human cell, a biological masterpiece unfolds not as a simple string of code but as a dynamic, three-dimensional sculpture that dictates life itself. A landmark study has now provided the most detailed and extensive atlas of this hidden architecture,
A promising class of anti-cancer drugs, designed with pinpoint precision to kill tumor cells, was abruptly sidelined by a mysterious and life-threatening side effect, leaving a potential breakthrough in oncology on the shelf. This clinical roadblock highlighted a fundamental challenge in modern
The perplexing reality that a medication meticulously designed to target cancer cells in the lungs can unexpectedly trigger adverse reactions in the heart has long been one of pharmacology's most frustrating and dangerous puzzles. For decades, the path a drug takes after being administered has been
In the complex world of hematologic malignancies, T-cell cancers represent a formidable challenge, often leaving patients with grim prognoses. We sat down with biopharma expert Ivan Kairatov to discuss a groundbreaking new approach that offers a glimmer of hope. In our conversation, he illuminates
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72